UN to G7: Production of safe COVID-19 vaccines must outweigh profit

• Nine independent experts said it was time for international solidarity and cooperation.
• Billions of people in the Global South are being left behind.
• UN experts urged pharmaceutical companies to join WHO’s COVID-19 Technology Access Pool.

---

“Everyone has a right to have access to a vaccine for COVID-19 that is safe, effective, timely and based on the application of the best scientific development”, the experts said ahead of the three-day Summit of the G7 intergovernmental group of leading countries in the United Kingdom, which begins on Friday.

No time for barriers

The nine independent experts said it was time for “international solidarity and cooperation” to assist all Governments in vaccinating people and saving lives.

“It is not the time for protracted negotiations or for lobbying to erect barriers in order to protect corporate profits”, they underscored.

Despite the extraordinarily speedy production of safe and effective COVID-19 vaccines, swift action has not followed to aid equal access across all countries and regions.

“Billions of people in the Global South are being left behind. They see vaccines as a mirage or a privilege for the developed world”, explained the experts, which, they added, would “unnecessarily prolong the crisis, drastically increase the death toll and deepen economic distress, possibly sowing the seeds of social unrest.”

Prioritize equity

The rights experts echoed their statement of last year on the human costs of the pandemic, saying that at a time when millions face poverty and hunger, G7 leaders must make it their top priority to protect the life and health of people in the most socially and economically precarious situations.

“It is shocking that, according to World Health Organization (WHO) reports, less than one percent of all vaccines administered so far have gone to low-income countries”, they pointed out, stressing that intellectual property rights must not become a barrier to low-cost production and expanded supply.

Human rights

The UN experts urged pharmaceutical companies to join WHO’s COVID-19 Technology Access Pool (C-TAP) for sharing know-how, data and intellectual property and recalled that while the TRIPs Agreement on intellectually property rights provides for certain flexibilities, including the possibility of compulsory licensing in cases of national emergency, they are insufficient to respond to the current pandemic.

“Maximizing production of safe vaccines must take precedence over profiting from a global pandemic”, they said. “States must ensure that legal protection for intellectual property and patents doesn’t undermine the right of everyone to get access to a safe, timely and effective vaccine”.

The experts reminded States to align their actions with the UN Guiding Principles on Business and Human Rights and ensure that multilateral institutions, such as the World Trade Organization (WTO), “neither restrain the ability of their member States to meet their duty to protect nor hinder business enterprises from respecting human rights.”

Maximizing production of safe vaccines must take precedence over profiting from a global pandemic.